ARTICLE | Clinical News
Cervarix regulatory update
July 25, 2016 7:00 AM UTC
The China FDA approved Cervarix HPV vaccine from GlaxoSmithKline to prevent cervical cancer in women ages 9-25. GSK plans to launch the product in China in early 2017. The HPV types 16 and 18 vaccine ...